Since the NUCB2/nesfatin‐1 receptor has not yet been discovered, additional in vivo and in vitro researches are recommended to further investigate the role of NUCB2/nesfatin‐1 in the pathogenesis of GC. The gene discussed is NUCB2; the disease is gastric cancer.